dimanche 30 octobre 2016

Circulating tumour cells present genomic alterations which could be exploited to treat

Whole genomic copy number alterations in circulating tumor cells from men with abiraterone or enzalutamide resistant metastatic castration-resistant prostate cancer: separation of those cells and then a complex genomic analysis, comparison  with white blood cells and identification of targets.

Aucun commentaire: